Emergence of quinolone resistance among chicken isolates of campylobacter in Turkey

Turkish Journal of Veterinary and Animal Sciences

Volumn 28, Issue 2, 2004, Pages 391-397

  Savaşan, Serap ^a   Çiftçi, Alper ^b   Diker, Kadir Serdar ^b  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Campylobacter; Chicken; Quinolone; Resistance

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; NALIDIXIC ACID; QUINOLONE;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CHICKEN; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POULTRY; TURKEY (REPUBLIC);

ANIMALIA; BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; GALLUS GALLUS; NEGIBACTERIA;

EID: 2342581378     PISSN: 13000128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Shane, S.M.: The significance of Campylobacter jejuni infection in poultry: a review. Avian Pathol. 1992; 21: 189-213.
2. Hald, B., Knudsen, K., Lind, P., Madsen, M.: Study of the infectivity of saline-stored Campylobacter jejuni for day-old chicks. Appl. Environ. Microbiol. 2001; 67: 2388-2392.
3. Yildiz, A., Diker, K.S.: Campylobacter contamination in chicken carcasses. Turk. J. Vet. Anim. Sci. 1992; 16: 433-439.
4. Saenz, Y., Zarazaga, M., Lantero, M., Gastanares, M., Baquero, F., Torres, C.: Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob. Agents Chemother. 2000; 44: 267-271.
5. Skirrow, M.B.: Epidemiology of Campylobacter enterit. Int. J. Food Microbiol. 1991; 12: 9-16.
6. Hooper, D.C.: Mechanisms of fluoroquinolone resistance. Drug Resist. Updates 1999; 2: 38-55.
7. Hooper, D.C.: Clinical applications of quinolones. Biochim. Biophys. Acta 1998; 1400: 45-61.
8. Piddock, L.J.V.: Quinolone resistance and Campylobacter. Clin. Microbiol. Infect. 1999; 5: 239-243.
9. Engberg, J., Gerner-Smidt, P., Aarestrup, F.M., Taylor, D.E., Nachamkin, I.: Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 2001; 7: 24-35.
10. Gibreel, A., Sjogren, E., Kaijser, B., Wretlind, B., Skold, O.: Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC. Antimicrob. Agents Chemother. 1998; 42: 3276-3278.
11. Ruiz, J., Goni, P., Marco, F., Gallardo, F., Mirelis, B., Jimenez de Anta, M.T., Vila, J.: Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol. Immunol. 1998; 42: 223-226.
12. Hoge, C.W., Gambel, J.M.: Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin. Infect. Dis. 1998; 26: 341-345.
13. Prats, G., Mirelis, B., Llovet, T., Munoz, C., Miro, E., Navarro, F.: Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob. Agents Chemother. 2000; 44: 1140-1145.
14. Lau, S.K.P., Woo, P.C.Y., Leung, K.W., Yuen, K.Y.: Emergence of cotrimoxazole- and quinolone-resistant Campylobacter infections in bone marrow transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 2002; 21: 127-129.
15. Van Looveren, M., Daube, G., De Zutter, L., Dumont, J.M., Lammens, C., Wydooghe, M., Vandamme, P., Jouret, M., Cornelis, M., Goossens, H.: Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J. Antimicrob. Chemother. 2001; 48: 235-240.
16. Diker, K.S.: In vitro susceptibility of campylobacters isolated from poultry to enrofloxacin and ciprofloxacin. Acta Gastroenterol. Belgica 1993; 56 (suppl.): 36.
17. Diker, K.S.: Studies on the identification of Campylobacter species isolated from sheep and cattle. Turk. J. Vet. Anim. Sci. 1985; 9: 232-240.
18. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. 8th Informational Suppl. NCCLS document M100-S8. 1998, National Committee for Clinical Laboratory Standards, Wayne, PA.
19. World Health Organization: Use of quinolones in food animals and potential impact on human health. Report of a WHO Meeting. Report WHO/EMC/ZDI/98.10, 1998, World Health Organization, Geneva, Switzerland.
20. Thomson, C.J.: The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective. J. Antimicrob. Chemother. 1999; 43(Suppl. A): 31-40.
21. Van Diest, J., De Jong, A.: Overview of quinolone usage for food-producing animals. In: Use of quinolones in food animals and potential impact on human health. Report and Proceedings of a WHO Meeting. Geneva: World Health Organization, 1999; p. 97.
22. Gür, D., Hascelik, G., Akyon, Y., Akalin, H.H., Diker, K.S.: In vitro susceptibility of Campylobacterjejuni and Campylobacter coli to quinolone antibiotics. Mikrobiyol. Bült. 1989; 23: 185-189.
23. Adler-Mosca, H., Altwegg, M.: Fluoroquinolone resistance in Campylobacter jejuni and C. coli isolated from human faeces in Switzerland. J. Infect. 1991; 23: 341-342.
24. Sjogren, E., Kaijser, B., Werner, M.: Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob. Agents Chemother. 1992; 36: 2847-2849.
25. Aquino, M.H.C., Filgueiras, A.L.L., Ferreira, M.C.S., Oliveira, S.S., Bastos, M.C., Tibana, A.: Antimicrobial resistance and plasmid profiles of Campylobacter jejuni and C. coli from human and animal sources. Lett. Appl. Microbiol. 2002; 34: 149-153.
26. Adler Mosca, H., Luthy-Hottenstein, J., Martinetti, G., Burnens, A.P., Altwegg, M.: Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 1991; 10: 953-957.
27. Segreti, J., Gootz, T.D., Goodman, L.J., Parkhurst, G.W., Quinn, J.P., Martin, B.A., Trenholme, G.M.: High-level quinolone resistance in clinical isolates of Campylobacterjejuni. J. Infect. Dis. 1992; 165: 667-670.
28. Jacobs-Reitsma, W.F., Kan, C.A., Bolder, N.M.: The induction of quinolone resistance in Campylobacter in broilers by quinolone treatment. Lett. Appl. Microbiol. 1994; 19: 228-231.
29. McDermott, P.F., Bodeis, S.M., English, L.L., White, D.G., Walker, R.D., Zhao, S., Simjee, S., Wagner, D.D.: Ciprofloxacin resistance in Campylobacterjejuni evolves rapidly in chickens treated with fluoroquinolones. J. Infect. Dis. 2002; 185: 837-840.
30. Halling-Sorensen, B., Nielsen, S.N., Lanzky, P.F., Ingerslev, P., Lützhoft, H.C.H., Jorgensen, S.E.: Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998; 36: 357-393.